Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,214 | 850 | 99.5% |
| Education | $75.23 | 26 | 0.5% |
| Gift | $0.01 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,980 | 102 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $1,478 | 93 | $0 (2024) |
| PFIZER INC. | $1,104 | 91 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,025 | 60 | $0 (2022) |
| GlaxoSmithKline, LLC. | $950.71 | 53 | $0 (2024) |
| ABBVIE INC. | $743.94 | 56 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $728.69 | 55 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $471.49 | 36 | $0 (2023) |
| Electronic Waveform Lab, Inc. | $436.37 | 11 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $398.54 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,473 | 76 | AstraZeneca Pharmaceuticals LP ($445.89) |
| 2023 | $1,471 | 83 | AstraZeneca Pharmaceuticals LP ($383.33) |
| 2022 | $2,277 | 138 | Scilex Pharmaceuticals Inc. ($327.54) |
| 2021 | $2,443 | 154 | SCILEX PHARMACEUTICALS INC. ($416.59) |
| 2020 | $2,187 | 109 | SCILEX PHARMACEUTICALS INC. ($413.75) |
| 2019 | $1,448 | 96 | PFIZER INC. ($211.84) |
| 2018 | $1,569 | 108 | PFIZER INC. ($312.41) |
| 2017 | $1,421 | 113 | PFIZER INC. ($283.95) |
All Payment Transactions
877 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Cardio-renal | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.23 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: PAIN | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.11 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: PAIN | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: PAIN | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: PAIN | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: PAIN | ||||||
| 09/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.80 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Pain Management | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: PAIN | ||||||
| 08/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.09 | General |
| Category: Cardiovascular | ||||||
| 08/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $31.57 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: PAIN | ||||||
| 08/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 325 | 2,846 | $365,540 | $160,355 |
| 2022 | 5 | 339 | 2,490 | $383,340 | $170,902 |
| 2021 | 6 | 349 | 2,542 | $423,550 | $192,068 |
| 2020 | 6 | 368 | 2,726 | $435,770 | $152,894 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 163 | 1,744 | $348,800 | $156,506 | 44.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 51 | 194 | $3,880 | $2,188 | 56.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 19 | $2,850 | $698.83 | 24.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 44 | 112 | $2,240 | $633.20 | 28.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 51 | 777 | $7,770 | $329.52 | 4.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 1,799 | $359,800 | $164,489 | 45.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 44 | 104 | $15,600 | $4,656 | 29.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 40 | 98 | $1,960 | $1,120 | 57.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 45 | 109 | $2,180 | $470.98 | 21.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 38 | 380 | $3,800 | $165.74 | 4.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 195 | 1,986 | $397,200 | $184,270 | 46.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 35 | 105 | $15,750 | $5,182 | 32.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $4,500 | $1,263 | 28.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 32 | 64 | $1,280 | $748.44 | 58.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 37 | 113 | $2,260 | $507.77 | 22.5% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 32 | 256 | $2,560 | $96.27 | 3.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 197 | 2,094 | $410,520 | $145,722 | 35.5% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 33 | 85 | $12,750 | $4,026 | 31.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 37 | $5,550 | $1,548 | 27.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 35 | 90 | $1,800 | $1,001 | 55.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 35 | 95 | $1,900 | $442.07 | 23.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2020 | 35 | 325 | $3,250 | $154.91 | 4.8% |
About Dr. Frank Fine, MD
Dr. Frank Fine, MD is a General Practice healthcare provider based in Modesto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700981016.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Fine, MD has received a total of $14,289 in payments from pharmaceutical and medical device companies, with $1,473 received in 2024. These payments were reported across 877 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($14,214).
As a Medicare-enrolled provider, Fine has provided services to 1,381 Medicare beneficiaries, totaling 10,604 services with total Medicare billing of $676,220. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Location Modesto, CA
- Active Since 09/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1700981016
Products in Payments
- ZTLido (Drug) $1,062
- LATUDA (Drug) $1,025
- FARXIGA (Drug) $699.50
- REXULTI (Drug) $662.63
- UBRELVY (Drug) $621.36
- LYRICA (Drug) $550.31
- TRELEGY ELLIPTA (Drug) $508.95
- BREZTRI (Drug) $457.45
- ELIQUIS (Drug) $439.48
- NURTEC ODT (Drug) $420.78
- XARELTO (Drug) $339.41
- SYMBICORT (Drug) $334.39
- AIRSUPRA (Drug) $313.60
- VRAYLAR (Drug) $304.70
- ABILIFY MAINTENA (Drug) $298.81
- AUSTEDO (Drug) $251.70
- ANORO ELLIPTA (Drug) $223.09
- Trintellix (Drug) $215.10
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $212.28
- Kerendia (Drug) $207.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Modesto
Dr. Amandeep Gill, Dds, DDS
General Practice — Payments: $10,973
Dr. Marinello Manuel, D.m.d, D.M.D
General Practice — Payments: $8,995
Dr. Donald Hillock, Dds, DDS
General Practice — Payments: $7,206
Dr. Galen Filbrun, D.d.s, D.D.S
General Practice — Payments: $4,134
Dr. Phil Chen, Dds, DDS
General Practice — Payments: $3,828
Brady Marshall, D.m.d, D.M.D
General Practice — Payments: $3,462